Abstract #1036

Detecting in vivo urokinase Plasminogen Activator activity with a catalyCEST MRI contrast agent

Sanhita Sinharay¹, Christine M. Howison², Amanda F. Baker³, and Mark D. Pagel²

¹Chemistry and Biochemistry, University of Arizona, Tucson, AZ, United States, ²Medical Imaging, University of Arizona, Tucson, AZ, United States, ³University of Arizona Cancer Center, University of Arizona, Tucson, AZ, United States

SYNOPSIS: We have designed a nonmetallic contrast agent, GR-4Am-SA, that can detect the activity of urokinase Plasminogen Activator with CEST MRI. uPA cleaves a peptide of the agent which causes CEST at 5.0 ppm to decrease, but CEST at 9.5 ppm is unchanged. The two CEST signals were used to determine a reaction coordinate, representing the extent of enzyme-catalyzed cleavage of the GR-4Am-SA agent. GR-4Am-SA detected uPA activity in solution, and in a flank xenograft model of Capan-2 pancreatic cancer.

How to access this content:

For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.

After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.

After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.

Click here for more information on becoming a member.